2011
DOI: 10.1037/a0021873
|View full text |Cite
|
Sign up to set email alerts
|

Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease.

Abstract: Objective-Individuals with the trinucleotide CAG expansion (CAG+) that causes Huntington disease (HD) have impaired performance on antisaccade (AS) tasks that require directing gaze in the mirror opposite direction of visual targets. This study aimed to identify the neural substrates underlying altered antisaccadic performance.Method-Three groups of participants were recruited: 1) Imminent and early manifest HD (early HD, n=8); 2) premanifest (presymptomatic) CAG+ (preHD, n=10); and 3) CAG unexpanded (CAG−) co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
7
0

Year Published

2012
2012
2016
2016

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 110 publications
(198 reference statements)
0
7
0
Order By: Relevance
“…Antisaccade abnormalities have been documented for other polyglutamine diseases such as SCA1, SCA3 (Rivaud-Pechoux et al, 1998), SCA17 (Hubner et al, 2007) and Huntington Disease (Rupp et al, 2011), suggesting a special vulnerability to polyglutamine expansions of the cortical-subcortical networks underlying antisaccades, regardless of the specific expanded protein. Furthermore, for Huntington Disease, antisaccade abnormalities can be detected even some years before disease onset, being an early marker of disease onset in asymptomatic mutation carriers (Rupp et al, 2011).…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…Antisaccade abnormalities have been documented for other polyglutamine diseases such as SCA1, SCA3 (Rivaud-Pechoux et al, 1998), SCA17 (Hubner et al, 2007) and Huntington Disease (Rupp et al, 2011), suggesting a special vulnerability to polyglutamine expansions of the cortical-subcortical networks underlying antisaccades, regardless of the specific expanded protein. Furthermore, for Huntington Disease, antisaccade abnormalities can be detected even some years before disease onset, being an early marker of disease onset in asymptomatic mutation carriers (Rupp et al, 2011).…”
Section: Discussionmentioning
confidence: 97%
“…Furthermore, for Huntington Disease, antisaccade abnormalities can be detected even some years before disease onset, being an early marker of disease onset in asymptomatic mutation carriers (Rupp et al, 2011). Whether antisaccade abnormalities appear before the cerebellar ataxia in SCA2 is currently being tested in a large cohort of Cuban asymptomatic ATXN2 mutation carriers.…”
Section: Discussionmentioning
confidence: 98%
“…22 fMRI studies of antisaccade eye movement have also shown altered brain activation in task-related regions. 320 Studies of resting-state connectivity have shown reduced DMN connectivity in the anterior prefrontal cortex, inferior parietal lobe, and posterior cingulate, as well as reduced connectivity between cortical motor regions and the striatum in pre-HD patients. 321,322 Functional connectivity during a working memory task was also shown to be altered in patients with pre-HD in regions of the prefrontal cortex, striatum, and frontoparietal regions.…”
Section: Huntington's Diseasementioning
confidence: 99%
“…This widespread activity also occurs in patients with Huntington disease, but with progression of disease and an increase in antisaccade errors, there is loss of activity in presupplementary and dorsal anterior cingulate regions (76). In these patients, particularly with antisaccade error, activity is more widespread, indicating compensatory activation of cortex not normally involved in error monitoring (76).…”
Section: Huntington Diseasementioning
confidence: 96%